AcquisitionOther
Eton Pharmaceuticals, Inc. acquired Increlex (mecasermin injection)
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Eton Pharmaceuticals, Inc. -> Increlex (mecasermin injection) · $22,500
Expertise and strong relationships in pediatric endocrinology and leveraging existing sales team to increase awareness of SPIGFD.
Open source record (SEC) ↗